JP2024524895A5 - - Google Patents
Info
- Publication number
- JP2024524895A5 JP2024524895A5 JP2023576368A JP2023576368A JP2024524895A5 JP 2024524895 A5 JP2024524895 A5 JP 2024524895A5 JP 2023576368 A JP2023576368 A JP 2023576368A JP 2023576368 A JP2023576368 A JP 2023576368A JP 2024524895 A5 JP2024524895 A5 JP 2024524895A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- sequence described
- csp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163211820P | 2021-06-17 | 2021-06-17 | |
| US63/211,820 | 2021-06-17 | ||
| PCT/US2022/033877 WO2022266383A1 (en) | 2021-06-17 | 2022-06-16 | Anti-csp antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024524895A JP2024524895A (ja) | 2024-07-09 |
| JP2024524895A5 true JP2024524895A5 (cg-RX-API-DMAC7.html) | 2025-06-23 |
Family
ID=84526612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023576368A Pending JP2024524895A (ja) | 2021-06-17 | 2022-06-16 | 抗csp抗体 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11655290B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4355774A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024524895A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240047964A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117940450A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2022292722B2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL309422A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023014984A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022266383A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL322413A (en) * | 2023-02-03 | 2025-09-01 | Atreca Inc | Variants of anti-CSP antibody |
| WO2025194069A1 (en) * | 2024-03-15 | 2025-09-18 | Atreca, Inc. | Anti-csp antibody variants |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3954643B2 (ja) | 1991-11-16 | 2007-08-08 | グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム | マラリア原虫由来のCSおよびHBsAG間のハイブリッド蛋白質 |
| JP4334141B2 (ja) | 1998-04-20 | 2009-09-30 | グリカート バイオテクノロジー アクチェンゲゼルシャフト | 抗体依存性細胞傷害性を改善するための抗体のグリコシル化操作 |
| US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
| US9221902B2 (en) * | 2008-11-07 | 2015-12-29 | Fabrus, Inc. | Combinatorial antibody libraries and uses thereof |
| SG10201900183VA (en) * | 2011-04-28 | 2019-05-30 | Univ Leland Stanford Junior | Identification of polynucleotides associated with a sample |
| KR20180029253A (ko) * | 2015-07-22 | 2018-03-20 | 유레카 쎄라퓨틱스, 인코포레이티드 | Psa 펩티드/mhc 복합체를 표적화하는 구축물 및 그의 용도 |
| US11066464B2 (en) * | 2016-03-21 | 2021-07-20 | Kymab Limited | Anti-malarial antibodies that bind circumsporozoite protein |
| US20220195023A1 (en) | 2019-02-19 | 2022-06-23 | Atreca, Inc. | Anti-csp antibody variants |
-
2022
- 2022-06-16 CN CN202280053427.0A patent/CN117940450A/zh active Pending
- 2022-06-16 KR KR1020247001320A patent/KR20240047964A/ko active Pending
- 2022-06-16 US US17/842,351 patent/US11655290B2/en active Active
- 2022-06-16 JP JP2023576368A patent/JP2024524895A/ja active Pending
- 2022-06-16 EP EP22825865.3A patent/EP4355774A4/en active Pending
- 2022-06-16 AU AU2022292722A patent/AU2022292722B2/en active Active
- 2022-06-16 WO PCT/US2022/033877 patent/WO2022266383A1/en not_active Ceased
- 2022-06-16 IL IL309422A patent/IL309422A/en unknown
- 2022-06-16 MX MX2023014984A patent/MX2023014984A/es unknown
-
2023
- 2023-01-26 US US18/101,933 patent/US12545723B2/en active Active
-
2025
- 2025-08-19 AU AU2025220692A patent/AU2025220692A1/en active Pending